CLINICAL_TRIALS
trial_result
· 2009-03-31
Clinical Trial Update: The Efficacy and Safety of FE 200486 in Treatment of Patients Suffering From Prostate Cancer [Phase 2]
Summary
A Phase 2 clinical trial update evaluating FE 200486 for efficacy and safety in prostate cancer has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ferring Pharmaceuticals | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2009-03-31